Dashenlin Pharm Grp Co Ltd (603233.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100002RG2
Dashenlin Pharm Grp Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 26.50 bn CNY | 27.50 bn CNY |
| Gross profit | 9.07 bn CNY | 9.44 bn CNY |
| Operating income | 1.35 bn CNY | 2.10 bn CNY |
| EBIT | 1.55 bn CNY | 1.93 bn CNY |
| Net income | 914.75 m CNY | 1.24 bn CNY |
| Diluted EPS – continuing operations | 0.81 CNY | 1.08 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Dashenlin Pharm Grp Co Ltd
DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
More stocks
- JA Solar Technology Co Ltd (002459.SZ)
- Inchcape PLC (INCH.L)
- Xi an Bright Laser Tech Co Ltd (688333.SS)
- Hubei Zhenhua Chemical Co Ltd (603067.SS)
- Jason Furniture(Hangzhou) (603816.SS)
- Luxi Chemical Group Co Ltd (000830.SZ)
- STO Express Co Ltd (002468.SZ)
- Huron Consulting Group Inc. (HURN)
- Harbin Electric Co Ltd (1133.HK)
- Beibuwan Port Co Ltd (000582.SZ)
- Comet Holding AG (COTN.SW)
- Shihlin Electric & Engineering Corp (1503.TW)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.